Gottlieb: Real Risk Of Congressional Action If Anti-Competitive Actions Continue

To remain shielded from political forces that could change incentives, pharmaceutical industry must adopt 'a certain set of values,' US FDA Commissioner says.

Commissioner Gottlieb speaking at RAPS 2017

US FDA Commissioner Scott Gottlieb warned industry that Capitol Hill tolerance for continued gaming of the system to prevent competition and keep prices high is waning.

During his May 3 address to the Food and Drug Law Institute's Annual Conference, Gottlieb said Congress could start making...

More from US FDA

More from Agency Leadership